Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Change in Receivables (2020 - 2025)

Celularity (CELU) has disclosed Change in Receivables for 6 consecutive years, with -$4.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Receivables rose 5.04% to -$4.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.0 million, a 135.03% decrease, with the full-year FY2024 number at $4.0 million, down 41.88% from a year prior.
  • Change in Receivables was -$4.5 million for Q3 2025 at Celularity, down from -$3.8 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $6.7 million in Q4 2023 to a low of -$4.8 million in Q3 2024.
  • A 5-year average of $488684.2 and a median of $844000.0 in 2021 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: surged 717.65% in 2021, then tumbled 1883.33% in 2025.
  • Celularity's Change in Receivables stood at $1.2 million in 2021, then fell by 22.42% to $896000.0 in 2022, then surged by 648.77% to $6.7 million in 2023, then fell by 25.15% to $5.0 million in 2024, then tumbled by 190.5% to -$4.5 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Change in Receivables are -$4.5 million (Q3 2025), -$3.8 million (Q2 2025), and $1.3 million (Q1 2025).